Trial intelligence / Profile preview

BWC0977 SAD and MAD in Healthy Adult Volunteers

NCT07029932Phase 1Recruiting

Sponsor
Bugworks Research Inc.
Start
Oct 2025
Primary completion
Jun 2027
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in infectious disease comparing BWC0977 with Placebo (2 arms). Primary endpoint: Incidence of treatment-emergent adverse events and serious adverse events. Started Oct 2025; status: recruiting.

02

Drugs

BWC0977
03

Conditions

infectious disease

Beyond the preview

Go deeper on NCT07029932.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07029932.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call